125 related articles for article (PubMed ID: 8587280)
1. Post-transplant hypertension and chronic renal allograft failure.
Paul LC; Benediktsson H
Kidney Int Suppl; 1995 Dec; 52():S34-7. PubMed ID: 8587280
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function.
Benediktsson H; Chea R; Davidoff A; Paul LC
Transplantation; 1996 Dec; 62(11):1634-42. PubMed ID: 8970620
[TBL] [Abstract][Full Text] [Related]
3. Does antihypertensive therapy modify chronic allograft failure?
Raine AE
Kidney Int Suppl; 1995 Dec; 52():S107-11. PubMed ID: 8587270
[TBL] [Abstract][Full Text] [Related]
4. Functional and histologic characteristics of chronic renal allograft rejection.
Paul LC
Clin Transplant; 1994 Jun; 8(3 Pt 2):319-23. PubMed ID: 8061373
[TBL] [Abstract][Full Text] [Related]
5. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
6. Renal N(epsilon)-carboxymethyllysine deposition after kidney transplantation.
Baumann M; Caron M; Schmaderer C; Schulte C; Viklicky O; von Weyhern CW; Lutz J; Heemann U
Transplantation; 2008 Jul; 86(2):330-5. PubMed ID: 18645498
[TBL] [Abstract][Full Text] [Related]
7. Renal mass as a determinant of late allograft outcome: insights from experimental studies in rats.
Mackenzie HS; Azuma H; Rennke HG; Tilney NL; Brenner BM
Kidney Int Suppl; 1995 Dec; 52():S38-42. PubMed ID: 8587281
[TBL] [Abstract][Full Text] [Related]
8. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
Smit-van Oosten A; Navis G; Stegeman CA; Joles JA; Klok PA; Kuipers F; Tiebosch AT; van Goor H
J Pathol; 2001 May; 194(1):122-9. PubMed ID: 11329151
[TBL] [Abstract][Full Text] [Related]
9. [Post-transplant nephropathy and arterial hypertension].
Oko A; Idasiak-Piechocka I; Czekalski S
Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
[TBL] [Abstract][Full Text] [Related]
10. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
11. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection.
Knoll T; Oltersdorf J; Göttmann U; Schaub M; Michel MS; Kirchengast M; van der Woude FJ; Rohmeiss P; Braun C
Transpl Int; 2003 Jun; 16(6):425-9. PubMed ID: 12819874
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
13. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
[TBL] [Abstract][Full Text] [Related]
14. Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients.
Koch M; Mengel M; Poehnert D; Nashan B
Transplantation; 2007 Feb; 83(4):498-505. PubMed ID: 17318083
[TBL] [Abstract][Full Text] [Related]
15. [Arterial hypertension in renal transplant recipients].
Basić-Jukić N; Jurić I; Kes P; Bubić-Filipi L; Brunetta B; Pasini J
Acta Med Croatica; 2007 Apr; 61(2):171-6. PubMed ID: 17585473
[TBL] [Abstract][Full Text] [Related]
16. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
17. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L
Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of chronic renal allograft dysfunction].
Morozumi K; Takeda A; Uchida K
Hinyokika Kiyo; 2002 Nov; 48(11):673-7. PubMed ID: 12512140
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlation between renal allograft failure and hyperlipidemia.
Guijarro C; Massy ZA; Kasiske BL
Kidney Int Suppl; 1995 Dec; 52():S56-9. PubMed ID: 8587285
[TBL] [Abstract][Full Text] [Related]
20. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.
Pratt JR; Hibbs MJ; Laver AJ; Smith RA; Sacks SH
Am J Pathol; 1996 Dec; 149(6):2055-66. PubMed ID: 8952538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
